UK markets close in 16 minutes

Xenon Pharmaceuticals Inc. (XENE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
39.74+1.67 (+4.40%)
As of 11:13AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-188,597
-182,393
-125,373
-78,882
-28,837
-
Depreciation & amortisation
3,786
3,541
1,624
906
644
-
Deferred income taxes
-177
-292
-44
58
-285
-
Stock-based compensation
35,778
32,372
20,376
10,017
5,677
-
Change in working capital
-2,581
5,635
-676
-2,647
-26,089
-
Accounts receivable
-58
130
1,757
-459
-1,032
-
Other working capital
-157,693
-150,944
-101,324
-71,552
-50,761
-
Other non-cash items
-
-
-
-
216
525
Net cash provided by operating activities
-154,094
-145,327
-98,430
-69,502
-48,124
-
Cash flows from investing activities
Investments in property, plant and equipment
-3,599
-5,617
-2,894
-2,050
-2,637
-
Purchases of investments
-862,473
-793,907
-551,137
-389,474
-228,897
-
Sales/maturities of investments
656,078
682,354
258,028
144,754
214,710
-
Net cash used for investing activities
-209,994
-117,170
-296,003
-246,770
-16,824
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-16,743
0
Common stock issued
-
353,487
277,766
447,283
102,456
-
Net cash used provided by (used for) financing activities
-
353,522
278,471
447,543
85,795
-
Net change in cash
-10,616
91,401
-118,446
130,679
20,254
-
Cash at beginning of period
69,512
57,242
175,688
45,009
24,755
-
Cash at end of period
58,946
148,643
57,242
175,688
45,009
-
Free cash flow
Operating cash flow
-154,094
-145,327
-98,430
-69,502
-48,124
-
Capital expenditure
-3,599
-5,617
-2,894
-2,050
-2,637
-
Free cash flow
-157,693
-150,944
-101,324
-71,552
-50,761
-